GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T45.695A
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
ICD10CM code
Medical Policies and Guidelines for Adverse effect of other fibrinolysis-affecting drugs, initial encounter
Related policies from health plans
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
T45.695A
- Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695D
- Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.605A
- Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605D
- Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.695
- Adverse effect of other fibrinolysis-affecting drugs
T45.615A
- Adverse effect of thrombolytic drugs, initial encounter
T45.695S
- Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.696A
- Underdosing of other fibrinolysis-affecting drugs, initial encounter
T45.615D
- Adverse effect of thrombolytic drugs, subsequent encounter
T45.694A
- Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
HCPCS codes
G8696
- Antithrombotic therapy prescribed at discharge
G8969
- Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G9929
- Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardi
G8968
- Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
J3246
- Injection, tirofiban hcl, 0.25 mg
D9630
- OTHER DRUGS AND/OR MEDICAMENTS
J3101
- Injection, tenecteplase, 1 mg
G8935
- Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (
G8506
- Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb
G8972
- One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
CPT4 codes
85390
- Fibrinolysins or coagulopathy screen, interpretation and report
85410
- Fibrinolytic factors and inhibitors; alpha-2 antiplasmin
85290
- Clotting; factor XIII (fibrin stabilizing)
85415
- Fibrinolytic factors and inhibitors; plasminogen activator
36593
- Declotting by thrombolytic agent of implanted vascular access device or catheter
32561
- Instillation(s), via chest tube/catheter, agent for fibrinolysis (eg, fibrinolytic agent for break u
32562
- Instillation(s), via chest tube/catheter, agent for fibrinolysis (eg, fibrinolytic agent for break u
37195
- Thrombolysis, cerebral, by intravenous infusion
85397
- Coagulation and fibrinolysis, functional activity, not otherwise specified (eg, ADAMTS-13), each ana
92977
- Thrombolysis, coronary; by intravenous infusion